Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 6

Results: 20

Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1497, doi. 10.1007/s00262-021-03098-w

By:

Sun, Mengmeng;
Zeng, Han;
Jin, Kaifeng;
Liu, Zhaopei;
Hu, Baoying;
Liu, Chunnan;
Yan, Sen;
Yu, Yanze;
You, Runze;
Zhang, Hongyi;
Chang, Yuan;
Liu, Li;
Zhu, Yu;
Xu, Jiejie;
Xu, Le;
Wang, Zewei

Publication type:

Article

Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1545, doi. 10.1007/s00262-021-03094-0

By:

Conteduca, V.;
Medri, M.;
Mazzoni, L.;
De Giorgi, U.;
Stanganelli, I.

Publication type:

Article

Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1431, doi. 10.1007/s00262-021-03093-1

By:

Qin, Meng;
Hamanishi, Junzo;
Ukita, Masayo;
Yamanoi, Koji;
Takamatsu, Shiro;
Abiko, Kaoru;
Murakami, Ryusuke;
Miyamoto, Taito;
Suzuki, Haruka;
Ueda, Akihiko;
Hosoe, Yuko;
Horie, Akihito;
Yamaguchi, Ken;
Mandai, Masaki

Publication type:

Article

Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1519, doi. 10.1007/s00262-021-03092-2

By:

Li, Hui;
Wu, Miaofang;
Wu, Zhuna;
Liang, Jinxiao;
Wang, Lijuan;
Yang, Xi;
Lin, Zhongqiu;
Li, Jing

Publication type:

Article

Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1393, doi. 10.1007/s00262-021-03091-3

By:

Yang, Jin-Ji;
Huang, Cheng;
Fan, Yun;
Pan, Hongming;
Feng, Jifeng;
Jiang, Liyan;
Li, Xing-Ya;
Liu, Xiao-Qing;
Xiong, Jian-Ping;
Zhao, Yan-Qiu;
Cheng, Ying;
Ma, Rui;
Wang, Jie;
Wang, Yina;
Liu, Yan-Hui;
Lin, Dong-Mei;
Wang, Tao;
Shi, Wei;
Zou, Jianjun;
Wu, Yi-Long

Publication type:

Article

Clinical determinants of long-term survival in metastatic uveal melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1467, doi. 10.1007/s00262-021-03090-4

By:

Koch, Elias A. T.;
Petzold, Anne;
Wessely, Anja;
Dippel, Edgar;
Erdmann, Michael;
Heinzerling, Lucie;
Hohberger, Bettina;
Knorr, Harald;
Leiter, Ulrike;
Meier, Friedegund;
Mohr, Peter;
Rahimi, Farnaz;
Schell, Beatrice;
Schlaak, Max;
Terheyden, Patrick;
Schuler-Thurner, Beatrice;
Ugurel, Selma;
Utikal, Jochen;
Vera, Julio;
Weichenthal, Michael

Publication type:

Article

First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1345, doi. 10.1007/s00262-021-03089-x

By:

He, Mingfeng;
Zheng, Taihao;
Zhang, Xiaoyue;
Peng, Yuan;
Jiang, Xuan;
Huang, Yusheng;
Tan, Benxu;
Yang, Zhenzhou

Publication type:

Article

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1453, doi. 10.1007/s00262-021-03087-z

By:

Núñez, Kelley G.;
Sandow, Tyler;
Fort, Daniel;
Hibino, Mina;
Wright, Paige;
Cohen, Ari J.;
Thevenot, Paul T.

Publication type:

Article

Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1331, doi. 10.1007/s00262-021-03085-1

By:

Pan, Cheng;
Fujiwara, Yukio;
Horlad, Hasita;
Iriki, Toyohisa;
Shiraishi, Daisuke;
Komohara, Yoshihiro

Publication type:

Article

Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1479, doi. 10.1007/s00262-021-03084-2

By:

Ravirala, Divya;
Pei, Guangsheng;
Zhao, Zhongming;
Zhang, Xiaoliu

Publication type:

Article

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1443, doi. 10.1007/s00262-021-03083-3

By:

Yang, Kaili;
Han, Lu;
Wu, Shikai;
Qu, Xiujuan;
Li, Qin;
Zhao, Chuanhua;
Zhou, Jing;
Jin, Xuan;
Wang, Yusheng;
Yan, Dong;
Cheng, Zhiqiang;
Hua, Yuwei;
Zhang, Yan;
Ge, Yang;
Sun, Jinghua;
Deng, Wei;
Zhao, Lin;
Zhao, Yunbo

Publication type:

Article

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1357, doi. 10.1007/s00262-021-03078-0

By:

Takahashi, Miho;
Watanabe, Satoshi;
Suzuki, Ryo;
Arita, Masashi;
Sato, Ko;
Sato, Miyuki;
Sekiya, Yuki;
Abe, Yuko;
Fujisaki, Toshiya;
Ohtsubo, Aya;
Shoji, Satoshi;
Nozaki, Koichiro;
Ichikawa, Kosuke;
Kondo, Rie;
Saida, Yu;
Hokari, Satoshi;
Aoki, Nobumasa;
Hayashi, Masachika;
Ohshima, Yasuyoshi;
Koya, Toshiyuki

Publication type:

Article

Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1403, doi. 10.1007/s00262-021-03077-1

By:

Jiao, Defeng;
Zheng, Xiaohu;
Du, Xianghui;
Wang, Dong;
Hu, Ziming;
Sun, Rui;
Tian, Zhigang;
Fu, Binqing;
Wei, Haiming

Publication type:

Article

Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1313, doi. 10.1007/s00262-021-03076-2

By:

Guo, Jun-Nan;
Chen, Du;
Deng, Shen-Hui;
Huang, Jia-Rong;
Song, Jin-Xuan;
Li, Xiang-Yu;
Cui, Bin-Bin;
Liu, Yan-Long

Publication type:

Article

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1531, doi. 10.1007/s00262-021-03075-3

By:

Nickles, Emily;
Dharmadhikari, Bhushan;
Yating, Li;
Walsh, Robert J.;
Koh, Liang Piu;
Poon, Michelle;
Tan, Lip Kun;
Wang, Ling-Zhi;
Ang, Yvonne;
Asokumaran, Yugarajah;
Chong, Wan Qin;
Huang, Yiqing;
Loh, Kwok Seng;
Tay, Joshua;
Soo, Ross;
Koh, Mickey;
Ho, Liam Pock;
Chan, Marieta;
Niam, Madelaine;
Soh, Melissa

Publication type:

Article

Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1419, doi. 10.1007/s00262-021-03074-4

By:

Kiguchi, Toru;
Yamaguchi, Masaki;
Takezako, Naoki;
Miyawaki, Shuichi;
Masui, Koichi;
Ihara, Yuichiro;
Hirota, Masao;
Shimofurutani, Naoko;
Naoe, Tomoki

Publication type:

Article

Molecular imaging of cellular immunotherapies in experimental and therapeutic settings.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1281, doi. 10.1007/s00262-021-03073-5

By:

Shalaby, Nourhan;
Dubois, Veronica Phyllis;
Ronald, John

Publication type:

Article

Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1295, doi. 10.1007/s00262-021-03069-1

By:

Cao, Kui;
Liu, Mingdong;
Ma, Keru;
Jiang, Xiangyu;
Ma, Jianqun;
Zhu, Jinhong

Publication type:

Article

Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1507, doi. 10.1007/s00262-021-03063-7

By:

Wang, Bo;
He, Zhihua;
Yu, Hao;
Ou, Ziwei;
Chen, Junyu;
Yang, Meihua;
Fan, Xinxiang;
Lin, Tianxin;
Huang, Jian

Publication type:

Article

CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1371, doi. 10.1007/s00262-021-03057-5

By:

Sidorov, Semjon;
Fux, Lara;
Steiner, Katja;
Bounlom, Samyo;
Traxel, Sabrina;
Azzi, Tarik;
Berisha, Arbeneshe;
Berger, Christoph;
Bernasconi, Michele;
Niggli, Felix K.;
Perner, Yvonne;
Pather, Sugeshnee;
Kempf, Werner;
Nadal, David;
Bürgler, Simone

Publication type:

Article